|
Market Closed -
Nasdaq
04:00:00 2026-11-06 pm EST
|
5-day change | 1st Jan Change | ||
| 132.37 USD | +1.98% |
|
-8.35% | -27.52% |
| Nov. 03 | Axsome Therapeutics Could Achieve Earnings in 2027 Amid Growing Auvelity Revenue, RBC Says | MT |
| Nov. 03 | UBS Adjusts Axsome Therapeutics Price Target to $239 From $256, Maintains Buy Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AXSM | Delayed | |
CBOE
| AXSM | Real-time | |
|
Tradegate
| 19X | Real-time | |
|
London S.E.
| 0HKF | Delayed | |
|
Boerse Muenchen
| 19X | Real-time | |
|
Xetra
| 19X | Delayed | |
|
Deutsche Boerse AG
| 19X | Delayed | |
|
Börse Stuttgart
| 19X | Delayed | |
|
Borsa Italiana
| 1AXSM | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 144.43 | 193.45 | 185.96 |
| Spread/Res. | -8.35% | -31.57% | -28.82% |
| Spread/Supp. | +1.98% | +1.98% | +5.75% |
| Support | 129.8 | 129.8 | 125.17 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
